Michael Schwarz

University of Applied Sciences St Pölten

Also affiliated with Innovative Medicines Initiative, Medical University of Vienna, University of Tübingen

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 1 paper. Top paper: “Safety and efficacy of REP 2139-Mg in patients with HDV-related advanced liver disease in an international compassionate access program”.

Safety and efficacy of REP 2139-Mg in patients with HDV-related advanced liver disease in an international compassionate access program

Journal of Hepatology(2025)10.1016/j.jhep.2025.10.029

N/A

0.234DataRank · unranked

3 citations

V. Loustaud‐Ratti, Cihan Yurdaydın, Giuseppina Brancaccio, Mathias Jachs, Thomas Reiberger +41 more